Category: Economic Opportunity

Now What?

November 9, 2016 0

By Steve Buckstein Here at Cascade Policy Institute, as a nonprofit, nonpartisan think…

Read Blog Detail

Equal Outcome Is the Wrong Goal

January 14, 2015 0

In Governor Kitzhaber’s final inaugural address this week, he focused on the themes of equality and community. Specifically, he wants to reduce the gap between rich and poor. He also believes that only through collective action can we achieve that goal.

Read Blog Detail

Imagine a World…2015


Imagine a world where we buy our groceries in government stores. We can only shop at the store nearest our house. If we want to shop somewhere else, we’re forced to move our family into another neighborhood―if we can afford it.

Read Blog Detail

The Regime Trembles at the Sight of a Smartphone

January 6, 2015 0

“The regime trembles at the sight of a smartphone.”* That quote comes from Portland-based independent journalist and world traveler Michael J. Totten. One might guess that he wrote it about Portland’s city government and its aversion to ridesharing services like Uber that rely on smartphone apps to put riders and drivers together. But he didn’t.

Read Blog Detail

Let’s Talk Turkey – with Uncle Sam

November 24, 2014 0

On this Thanksgiving I have to give credit to The Blaze for alerting me to a serious issue of public concern. Apparently the U.S. government, in its collective wisdom, believes that Americans need its help to purchase, prepare, and eat the traditional holiday turkey.

Read Blog Detail

Shouldn’t the Terminally Ill Have the “Right to Try” to Save Their Lives?

October 22, 2014 0

Last Friday, Michigan approved Right to Try legislation with overwhelming bipartisan support. Colorado, Missouri, and Louisiana all passed similar measures this year, with Arizonans voting on the issue this November. What is Right to Try and why is it gaining steam?

Spearheaded by the Goldwater Institute, an Arizona-based public policy organization, Right to Try legislation allows terminally ill patients access to drugs, biotics, and implants that have completed basic FDA safety testing but are still awaiting further approval.

Read Blog Detail